By Ali Elias
In 1922, writes World Health Organisation (WHO), on Its X Page, insulin co-discoverer Frederick Banting refused to profit from the discovery & offered it to the world as a global public good. Today, many people with #diabetes still don’t have access to affordable and quality treatment and care.
In Reaction, , Raffaele Di Giacomo, PhD, says the story of Frederick Banting’s generosity is indeed remarkable and highlights a stark contrast to today’s challenges in accessing affordable diabetes treatment. It’s concerning that nearly a century later, many still struggle to obtain essential care for managing their condition. This calls for a deeper examination of healthcare policies and pharmaceutical practices globally. What strategies could potentially improve access to insulin and other vital medications for diabetes management?
Sage John Amenti blames the situation on the inconsiderate actions of stakeholders. He opines: greedy pharmaceutical companies are more interested in making obscene profits than in helping people. The price of drugs in this country is ridiculous. Big business(es) make us sick, advertisers fuel our addictions, doctors overcharge to treat us, and our government does little.